Tech Company Financing Transactions
PierianDx Funding Round
On 2/13/2018, PierianDx raised $3 million in financing from private investors.
Transaction Overview
Company Name
Announced On
2/13/2018
Transaction Type
Venture Equity
Amount
$3,046,458
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
77 Maryland Plz.
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Website
Email Address
Overview
PierianDx enables clinical labs to seamlessly manage and interpret complex genetic tests for the most effective patient care. For health systems, children's hospitals, comprehensive cancer centers and reference labs looking to bring next-generation sequencing in-house rapidly or one step at a time.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Rakesh Nagarajan
Chief Executive Officer
Michael Sanderson
Chief Medical Officer
Shalini Verma
Chief Operating Officer
Chris Callahan
VP - Marketing
Josh Forsythe
VP - Product Management
Andrew Bredemeyer
VP - Product Management
Bryce Daines
VP - Product Management
Mukesh Sharma
Browse more venture capital transactions:
Prev: 2/13/2018: Nooklyn venture capital transaction
Next: 2/13/2018: EverQuote venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs